An overview of human prion diseases

Virology Journal

Volumn 8, Issue , 2011, Pages

  Imran, Muhammad ^a   Mahmood, Saqib ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

CJD; Prion diseases; Prions; PRNP; TSE

Indexed keywords

PRION PROTEIN;

AGGRESSION; AGITATION; ALLELE; ANXIETY; APATHY; ATAXIA; BRAIN DISEASE; CAT; CATTLE; CEREBELLUM DISEASE; CHIMPANZEE; CLINICAL ASSESSMENT; CONCENTRATION LOSS; DEMENTIA; DEPRESSION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DNA POLYMORPHISM; DYSARTHRIA; DYSPHAGIA; ELECTROENCEPHALOGRAM; FAMILIAL CRUETZFELDT JACOB DISEASE; FATAL FAMILIAL INSOMNIA; GAIT DISORDER; GENE MUTATION; GENETIC SUSCEPTIBILITY; GOAT; HOMOZYGOSITY; HUMAN; IATROGENIC CRUETZFELDT JACOB DISEASE; INCIDENCE; INSOMNIA; KURU; MENTAL INSTABILITY; MINK; MYOCLONUS; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PARANOIA; PHENOTYPE; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRION DISEASE; PUBLIC HEALTH; PYRAMIDAL SIGN; REVIEW; RISK FACTOR; SCRAPIE; SHEEP; SPEECH DISORDER; SPORADIC CRUETZFELDT JACOB DISEASE; SPORADIC FATAL INSOMNIA; TANDEM REPEAT; VARIABLY PROTEASE SENSITIVE PRIONOPATHY; VISUAL DISORDER; WESTERN BLOTTING; ANIMAL; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; GENETICS; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; PATHOGENICITY; PATHOLOGY; PRION;

BOS; MAMMALIA;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; INSOMNIA, FATAL FAMILIAL; KURU; PRION DISEASES; PRIONS; PUBLIC HEALTH;

EID: 84857201877     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-559     Document Type: Review

References (87)

1. Physiology of the prion protein. Linden R, Martins VR, Prado MAM, Cammarota M, Izquierdo I, Brentani RR, Physiol Rev 2008 88 673 728 10.1152/physrev.00007.2007 18391177 (Pubitemid 351520090)
2. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB, Proc Natl Acad Sci USA 1993 90 10962 10966 10.1073/pnas.90.23.10962 7902575 (Pubitemid 23354348)
3. Prions. Prusiner SB, Proc Natl Acad Sci USA 1998 95 13363 13383 10.1073/pnas.95.23.13363 9811807 (Pubitemid 28525623)
4. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, Surewicz WK, Nat Struct Mol Biol 2011 18 504 506 10.1038/nsmb.2035 21441913
5. NMR solution structure of the human prion protein. Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F, Billeter M, Calzolai L, Wider G, Wuthrich K, Proc Natl Acad Sci USA 2000 97 145 150 10.1073/pnas.97.1.145 10618385 (Pubitemid 30055798)
6. A general model of prion strains and their pathogenicity. Collinge J, Clarke AR, Science 2007 318 930 936 10.1126/science.1138718 17991853 (Pubitemid 350098981)
7. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. Aguzzi A, J Neurochem 2006 97 1726 1739 10.1111/j.1471-4159.2006. 03909.x 16805779 (Pubitemid 43873663)
8. An overview of animal prion diseases. Imran M, Mahmood S, Virol J 2011 8 493 10.1186/1743-422X-8-493 22044871
9. Transmissible mink encephalopathy. Marsh RF, Hadlow WJ, Rev Sci Tech 1992 11 539 550 1535524
10. Other animal prion diseases. Sigurdson CJ, Miller MW, Brit Med Bull 2003 66 199 212 10.1093/bmb/66.1.199 14522860 (Pubitemid 37173503)
11. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. Williams ES, Young S, J Wildl Dis 1980 16 89 98 7373730
12. A novel progressive spongiform encephalopathy in cattle. Wells GAH, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R, Vet Rec 1987 121 419 420 10.1136/vr.121.18.419 3424605
13. Spongiform encephalopathy in a herd of greater kudu (Tragelaphus strepsiceros): epidemiological observations. Kirkwood JK, Cunningham AA, Wells GA, Wilesmith JW, Barnett JE, Vet Rec 1993 133 360 364 10.1136/vr.133.15.360 8256421
14. Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles. Kirkwood JK, Cunningham AA, Vet Rec 1994 135 296 303 10.1136/vr.135.13.296 7817514
15. Feline spongiform encephalopathy. Wyatt JM, Pearson GR, Gruffydd-Jones TJ, Feline Pract 1993 21 7 9
16. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Bons N, Mestre-Frances N, Belli P, Cathala F, Gajdusek DC, Brown P, Proc Natl Acad Sci USA 1999 96 4046 4051 10.1073/pnas.96.7.4046 10097160 (Pubitemid 29169033)
17. Degenerative disease of the central nervous system in New Guinea. The endemic occurrence of "kuru" in the native population. Gajdusek DC, Zigas V, New Engl J Med 1957 257 974 978 10.1056/NEJM195711142572005 13483871
18. U" ber eine eigenartige herdfo"rmige Erkrankung des Zentralnervensystems. Creutzfeldt HG, Z Gesamte Neurol Psychiatr 1920 57 1 19 10.1007/BF02866081
19. U" ber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem. Befunde. (Spastische Pseudosklerose- Encephalomyelopathie mit disseminierten Degenerationsherden). Jakob A, Z Gesamte Neurol Psychiatr 1921 64 147 228 10.1007/BF02870932
20. Zwei eigenartige Erkrankung des Zentralnervensystems nach Art der spatischen Pseudosklerose (Jakob). Kirschbaum WR, Z Neurol Pyschiatry 1924 92 175 220 10.1007/BF02877841
21. The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system. Richardson EP, Masters CL, Brain Pathol 1995 5 33 41 10.1111/j.1750-3639.1995.tb00575.x 7767489
22. Possible person-to-person transmission of Creutzfeldt-Jakob disease. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D, N Engl J Med 1974 290 692 693 4813735
23. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P, N Engl J Med 1986 315 997 1003 10.1056/NEJM198610163151605 3762620 (Pubitemid 16028581)
24. A new variant of Creutzfeldt-Jakob disease in the UK. Will RG, Ironside JW, Zeidler M, Cousens SM, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG, Lancet 1996 347 921 925 10.1016/S0140-6736(96)91412-9 8598754
25. Prion protein conformation in a patient with sporadic fatal insomnia. Mastrianni JA, Nixon R, Layzer R, Telling GC, Han D, DeArmond SJ, Prusiner SB, N Engl J Med 1999 340 1630 1638 10.1056/NEJM199905273402104 10341275 (Pubitemid 29249432)
26. A novel human disease with abnormal prion protein sensitive to protease. Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, Montine T, Wisniewski T, Dickson DW, Soto C, Hulette CM, Mastrianni JA, Kong Q, Zou WQ, Ann Neurol 2008 63 697 708 10.1002/ana.21420 18571782 (Pubitemid 351945529)
27. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Mead S, Stumpf MP, Whitfield J, Beck J, Poulter M, Campbell T, Uphill J, Goldstein D, Alpers MP, Fisher E, Collinge J, Science 2003 300 640 643 10.1126/science.1083320 12690204 (Pubitemid 36520588)
28. Transmissible spongiform encephalopathies in humans. Belay ED, Annu Rev Microbiol 1999 53 283 314 10.1146/annurev.micro.53.1.283 10547693 (Pubitemid 29503733)
29. Transmissible spongiform encephalopathies. Brandel JP, Orphanet Encyclopedia 2004 1 7 http://www.orpha.net/data/patho/GB/uk-TSE.pdf
30. Autopsy case of Creutzfeldt-Jakob disease with Met/Val heterozygosity at codon 129 and type 1protease-resistant prion protein presenting some florid-type plaques and many Kuru plaques in the cerebellum. Kawauchi Y, Kamitani T, Yagishita S, Kitamoto T, Kishida H, Neuropathology 2006 26 313 317 10.1111/j.1440-1789.2006.00683.x 16961067 (Pubitemid 44086834)
31. Visual symptoms in the Heidenhain variant of Creutzfeldt-Jakob Disease. Cornelius JR, Boes CJ, Ghearing G, Leavitt JA, Kumar N, J Neuroimaging 2009 19 283 287 10.1111/j.1552-6569.2008.00294.x 20704012
32. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Parchi P, Strammiello R, Giese A, Kretzschmar H, Acta Neuropathol 2011 121 91 112 10.1007/s00401-010-0779-6 21107851
33. Electrophysiologie des encéphalopathies transmissibles. Court L, Bert J, Path Biol 1995 43 25 42
34. Regulatory sequences of the PRNP gene influence susceptibility to sporadic Creutzfeldt-Jakob disease. Bratosiewicz-Wasik J, Liberski PP, Golanska E, Jansen GH, Wasik TJ, Neurosci Lett 2007 411 163 167 10.1016/j.neulet.2006.08. 001 17134829 (Pubitemid 44834557)
35. Sporadic - but not variant - Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Mead S, Mahal SP, Beck J, Campbell T, Farrall M, Fisher E, Collinge J, Am J Hum Genet 2001 69 1225 1235 10.1086/324710 11704923 (Pubitemid 33124204)
36. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Palmer MS, Dryden AJ, Hughes JT, Collinge J, Nature 1991 352 340 342 10.1038/352340a0 1677164 (Pubitemid 21912354)
37. Genetic basis of Creutzfeldt-Jakob disease in the United Kingom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Windl O, Dempster M, Estibeiro JP, Lathe R, De Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KCL, Palmer MS, Collinge J, Hum Genet 1996 98 259 264 10.1007/s004390050204 8707291 (Pubitemid 26258371)
38. Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Shibuya S, Higuchi J, Shin R-W, Tateishi J, Kitamoto T, Lancet 1998 351 419 9482304
39. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T, Ann Neurol 1998 43 826 828 10.1002/ana.410430618 9629853 (Pubitemid 28280227)
40. Prion susceptibility and protective alleles exhibit marked geographic differences. Soldevila M, Calafell F, Andrés AM, Yagüe J, Helgason A, Stefánsson K, Bertranpetit J, Hum Mutat 2003 22 104 104 12815605
41. Diversity of prion diseases: (no) strains attached? Brandner S, Acta Neuropathol 2011 121 1 4 10.1007/s00401-010-0775-x 21080180
42. Molecular biology and pathology of prion strains in sporadic human prion diseases. Gambetti P, Cali I, Notari S, Kong Q, Zou WQ, Surewicz WK, Acta Neuropathol 2011 121 79 90 10.1007/s00401-010-0761-3 21058033
43. Molecular pathology of human prion disease. Wadsworth JDF, Collinge J, Acta Neuropathol 2011 121 69 77 10.1007/s00401-010-0735-5 20694796
44. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P, Acta Neuropathol 2011 121 21 37 10.1007/s00401-010-0760-4 20978903
45. Familial and sporadic fatal insomnia. Montagna P, Gambetti P, Cortelli P, Lugaresi E, Lancet Neurol 2003 2 167 176 10.1016/S1474-4422(03)00323-5 12849238 (Pubitemid 37443320)
46. A case of fatal familial insomnia in Africa. Baldin E, Capellari C, Provini F, Corrado P, Liguori R, Parchi P, Montagna P, Cortelli P, J Neurol 2009 256 778 1779
47. Sporadic and familial CJD: classification and characterization. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG, Brit Med Bull 2003 66 213 239 10.1093/bmb/66.1.213 14522861 (Pubitemid 37173504)
48. A subtype of sporadic prion disease mimicking fatal familial insomnia. Parchi P, Capellari S, Chin S, Schwarz HB, Schecter NP, Butts JD, Hudkins P, Burns DK, Powers JM, Gambetti P, Neurology 1999 52 1757 1763 10371520 (Pubitemid 29260886)
49. An atypical case of sporadic fatal insomnia. Priano L, Giaccone G, Mangieri M, Albani G, Limido L, Brioschi A, Pradotto L, Orsi L, Mortara P, Fociani P, Mauro A, Tagliavini F, J Neurol Neurosurg Psychiatry 2009 80 924 927 10.1136/jnnp.2008.154815 19608785
50. Molecular cloning of a human prion protein cDNA. Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ, DNA 1986 5 315 324 10.1089/dna.1986.5.315 3755672 (Pubitemid 16049607)
51. Prospective 10-year surveillance of human prion diseases in Japan. Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M, Brain 2010 133 3043 3057 10.1093/brain/awq216 20855418
52. High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein. Corsaro A, Thellung S, Bucciarelli T, Scotti L, Chiovitti K, Villa V, D'Arrigo C, Aceto A, Florio T, Int J Biochem Cell Biol 2011 43 372 382 10.1016/j.biocel.2010.11.007 21094273
53. Familial spongiform encephalopathy with distinct clinico-pathological features associated with a novel prion gene mutation at codon 183. Nitrini R, Rosemberg S, Passos-Bueno MR, Teixeira da Silva LS, Iughetti P, Papadopoulos M, Carrilho PM, Caramelli P, Al- brecht S, Zatz M, LeBlanc A, Ann Neurol 1997 42 138 146 10.1002/ana.410420203 9266722 (Pubitemid 27340457)
54. A distinct phenotype of leg hyperreflexia in a Japanese family with Gerstmann-Sträussler-Scheinker syndrome (P102L). Takazawa T, Ikeda K, Ito H, Aoyagi J, Nakamura Y, Miura K, Iwamoto K, Kano O, Kawabe K, Iwasaki Y, Intern Med 2010 49 339 342 10.2169/internalmedicine.49.2864 20154442
55. Sleep and temperature rhythms in two sisters with P102L Gerstmann-Stra"ussler-Scheinker (GSS) disease. Provini F, Vetrugno R, Pierangeli G, Cortelli P, Rizzo G, Filla A, Strisciuglio C, Gallassi R, Montagna P, Sleep Med 2009 10 374 377 10.1016/j.sleep.2008.03.004 18550428
56. Gerstmann-Sträussler-Scheinker disease with P102L-V129 mutation: a case with psychiatric manifestations at onset. Bianca M, Bianca S, Vecchio I, Raffaele R, Ingegnosi C, Nicoletti F, Ann Genet 2003 46 467 469 10.1016/S0003-3995(03)00017-0 14659783 (Pubitemid 37456450)
57. Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Jansen C, Parchi P, Capellari S, Vermeij AJ, Corrado P, Baas F, Strammiello R, van Gool WA, van Swieten JC, Rozemuller AJ, Acta Neuropathol 2010 119 189 197 10.1007/s00401-009-0609-x 19911184
58. A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration. Alzualde A, Indakoetxea B, Ferrer I, Moreno F, Barandiaran M, Gorostidi A, Estanga A, Ruiz I, Calero M, van Leeuwen FW, Atares B, Juste R, Rodriguez-Martínez AB, Lápez de Munain A, J Neuropathol Exp Neurol 2010 69 789 800 10.1097/NEN.0b013e3181e85737 20613639
59. Kuru: its ramifications after fifty years. Liberski PP, Brown P, Exp Gerontol 2009 44 63 69 10.1016/j.exger.2008.05.010 18606515
60. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Will RG, Brit Med Bull 2003 66 255 265 10.1093/bmb/66.1.255 14522863 (Pubitemid 37173506)
61. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Collinge J, Palmer MS, Dryden AJ, Lancet 1991 337 1441 1442 10.1016/0140-6736(91)93128-V 1675319
62. Experimental transmission of a kuru-like syndrome to chimpanzee. Gajdusek DC, Gibbs CJ, Alpers M, Nature 1966 209 794 796 10.1038/209794a0 5922150
63. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Brandner S, Whitfield J, Boone K, Puwa A, O'Malley C, Linehan JM, Joiner S, Scaravilli F, Calder I, Alpers MP, Wadsworth JDF, Collinge J, Phil Trans R Soc B 2008 363 3755 3763 10.1098/rstb.2008.0091 18849292
64. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, Alpers MP, Lancet 2006 367 2068 2074 10.1016/S0140-6736(06)68930-7 16798390 (Pubitemid 43949290)
65. A novel protective prion protein variant that colocalizes with Kuru exposure. Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Campbell T, Al-Dujaily H, Hummerich H, Beck J, Mein CA, Verzilli C, Whittaker J, Alpers MP, Collinge J, N Engl J Med 2009 361 2056 2065 10.1056/NEJMoa0809716 19923577
66. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Wadsworth JDF, Joiner S, Linehan JM, Desbruslais M, Fox K, Cooper S, Cronier S, Asante EA, Mead S, Brandner S, Hill AF, Collinge J, Proc Nat Acad Sci USA 2008 105 3885 3890 10.1073/pnas.0800190105 18316717 (Pubitemid 351723494)
67. The kuru infectious agent is a unique geographic isolate distinct from Creutzfeldt-Jakob disease and scrapie agents. Manuelidis L, Chakrabarty T, Miyazawa K, Nduom NA, Emmerling K, Proc Natl Acad Sci USA 2009 106 13529 13534 10.1073/pnas.0905825106 19633190
68. Transmissible encephalopathy agents: virulence, geography and clockwork. Manuelidis L, Virulence 2010 1 101 104 10.4161/viru.1.2.10822 21178425
69. Variant Creutzfeldt-Jakob disease (vCJD): epidemiology and prevention from human to human secondary transmission. Beekes M, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010 53 597 605 10.1007/s00103-010-1070-7 20449549
70. Heterozygosity at polymorphic codon 219 in variant Creutzfeldt-Jakob disease. Lukic A, Beck J, Joiner S, Fearnley J, Sturman S, Brandner S, Wadsworth JD, Collinge J, Mead S, Arch Neurol 2010 67 1021 1023 10.1001/archneurol.2010. 184 20697057
71. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, Le Grice M, Ritchie DL, McCardle LM, Hilton DA, BMJ 2006 332 1164 1165 10.1136/bmj.332.7551.1164 16709965
72. PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism. Bishop MT, Pennington C, Heath CA, Will RG, Knight RS, BMC Med Genet 2009 10 146 10.1186/1471-2350-10-146 20035629
73. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Wadsworth JDF, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, Welch J, Stone L, Lloyd SE, Hill AF, Brandner S, Collinge J, Science 2004 306 1793 1796 10.1126/science.1103932 15539564 (Pubitemid 39601400)
74. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Asante EA, Linehan JM, Gowland I, Joiner S, Fox K, Cooper S, Osiguwa O, Gorry M, Welch J, Houghton R, Desbruslais M, Brandner S, Wadsworth JDF, Collinge J, Proc Natl Acad Sci USA 2006 103 10759 10764 10.1073/pnas.0604292103 16809423 (Pubitemid 44078049)
75. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. Hizume M, Kobayashi A, Teruya K, Ohashi H, Ironside JW, Mohri S, Kitamoto T, J Biol Chem 2009 284 3603 3609 19074151
76. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Hewitt P, Collinge J, Lancet 2006 368 2061 2067 10.1016/S0140-6736(06)69835-8 17161728 (Pubitemid 44855106)
77. A new human genotype prone to variant Creutzfeldt-Jakob disease. Wilson K, Ricketts MN, BMJ 2006 332 1164 1165 10.1136/bmj.332.7551.1164 16709965 (Pubitemid 44365443)
78. Variant CJD in an individual heterozygous for PRNP codon 129. Kaski D, Mead S, Hyare H, Cooper S, Jampana R, Overell J, Knight R, Collinge J, Rudge P, Lancet 2009 374 2128 10.1016/S0140-6736(09)61568-3 20109837
79. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari, Cashman NR, d'Aignaux JH, Cervena'kova' L, Fradkin J, Schonberger LB, Collins SJ, Neurology 2000 55 1075 1081 11071481
80. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, Shimoji M, Langeveld JP, Castellani R, Notari S, Crain B, Schmidt RE, Geschwind M, Dearmond SJ, Cairns NJ, Dickson D, Honig L, Torres JM, Mastrianni J, Capellari S, Giaccone G, Belay ED, Schonberger LB, Cohen M, Perry G, Kong Q, Parchi P, Tagliavini F, Gambetti P, Ann Neurol 2010 68 162 172 10.1002/ana.22094 20695009
81. The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. Jansen C, Head MW, van Gool WA, Baas F, Yull H, Ironside JW, Rozemuller AJ, J Neurol Neurosurg Psychiatry 2010 81 1052 1055 10.1136/jnnp.2009.175646 20547632
82. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: case report. Rodríguez-Martínez AB, Garrido JM, Zarranz JJ, Arteagoitia JM, de Pancorbo MM, Atarés B, Bilbao MJ, Ferrer I, Juste RA, BMC Neurol 2010 10 99 10.1186/1471-2377-10-99 20973975
83. Prions and protein-folding diseases. Norrby E, J Intern Med 2011 270 1 14 10.1111/j.1365-2796.2011.02387.x 21481020
84. Frequency distribution of PRNP polymorphisms in the Pakistani population. Imran M, Mahmood S, Hussain R, Abid NB, Lone KP, Gene 2012 492 186 194 10.1016/j.gene.2011.10.029 22062631
85. Polymorphisms of the PRNP gene in Chinese populations and the identification of a novel insertion mutation. Yu SL, Jin L, Sy MS, Mei FH, Kang SL, Sun GH, Tien P, Wang FS, Xiao GF, Eur J Hum Genet 2004 12 867 870 10.1038/sj.ejhg.5201245 15266305 (Pubitemid 39406073)
86. A novel three extra-repeat insertion in the prion protein gene (PRNP) in a patient with Creutzfeldt-Jakob disease. Grasbon-Frodl E, Schmalzbauer R, Weber P, Krebs B, Windl O, Zerr I, Kretzschmar HA, Neurogenetics 2004 5 249 250 10.1007/s10048-004-0196-x 15480878 (Pubitemid 40174646)
87. A case of Creutzfeldt-Jakob disease with a novel insertion mutation and codon 219 Lysine/Lysine polymorphism in the prion protein gene. Nishida Y, Sodeyama N, Toru Y, Toru S, Kitamoto T, Mizusawa H, Prions 2005 251 252